The benefits of exercise in progressive MS: some cautious optimism
Anthony Feinstein1,2
Ulrik Dalgas3
1Department of Psychiatry, Sunnybrook Health Sciences Centre, Canada
2University of Toronto, Canada
3Department of Public Health, Section of Sport Science, Aarhus University, Denmark
•Anthony Feinstein, Department of Psychiatry, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Toronto, ON M4N 3M5, Canada.
The therapeutic landscape in progressive multiple sclerosis (MS) is bleak. The promise of disease-modifying drugs has not extended to this subgroup of patients, which has meant that treatment is confined to symptom management. Here too the challenges are considerable given the greater all-around morbidity that accompanies the transition to a progressive disease course coupled with a dearth of clinical trials focusing specifically on this subgroup of patients. Cognizant of these challenges, researchers and clinicians from seven countries have recently joined forces to form a Progressive MS Alliance with a multiplicity of aims, one of which is to advance treatment options for patients left behind by the disease-modifying bandwagon. All of which makes the study by Briken et al. timely and important. (Abstract: http://activemsers.wssnoc.net/showthread.php?t=1437) The authors have shown that three different aerobic exercise modalities tailored according to a patient’s physical condition at baseline and undertaken two to three times a week over an eight- to 10-week period produced an array of benefits, including improved walking and cognition plus a reduction in fatigue and depression. Furthermore, a low drop-out rate suggests that patients were comfortable with the exercise intervention.
FULL ARTICLE (Read It!): http://msj.sagepub.com/content/20/3/269.full
Anthony Feinstein1,2
Ulrik Dalgas3
1Department of Psychiatry, Sunnybrook Health Sciences Centre, Canada
2University of Toronto, Canada
3Department of Public Health, Section of Sport Science, Aarhus University, Denmark
•Anthony Feinstein, Department of Psychiatry, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Toronto, ON M4N 3M5, Canada.
The therapeutic landscape in progressive multiple sclerosis (MS) is bleak. The promise of disease-modifying drugs has not extended to this subgroup of patients, which has meant that treatment is confined to symptom management. Here too the challenges are considerable given the greater all-around morbidity that accompanies the transition to a progressive disease course coupled with a dearth of clinical trials focusing specifically on this subgroup of patients. Cognizant of these challenges, researchers and clinicians from seven countries have recently joined forces to form a Progressive MS Alliance with a multiplicity of aims, one of which is to advance treatment options for patients left behind by the disease-modifying bandwagon. All of which makes the study by Briken et al. timely and important. (Abstract: http://activemsers.wssnoc.net/showthread.php?t=1437) The authors have shown that three different aerobic exercise modalities tailored according to a patient’s physical condition at baseline and undertaken two to three times a week over an eight- to 10-week period produced an array of benefits, including improved walking and cognition plus a reduction in fatigue and depression. Furthermore, a low drop-out rate suggests that patients were comfortable with the exercise intervention.
FULL ARTICLE (Read It!): http://msj.sagepub.com/content/20/3/269.full
Comment